SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006219
Filing Date
2024-03-01
Accepted
2024-03-01 07:35:13
Documents
17
Period of Report
2024-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240229_8k.htm   iXBRL 8-K 30892
2 EXHIBIT 99.1 ex_632981.htm EX-99.1 13738
7 ex_632981img001.jpg GRAPHIC 3755
  Complete submission text file 0001437749-24-006219.txt   187918

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240226.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240226_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240226_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240226_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240229_8k_htm.xml XML 2827
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 24706977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)